{"nct_id":"NCT02141204","title":"Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2019-02-20","start_date_type":"ACTUAL","primary_completion_date":"2019-12-28","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}